Tsung-Ying Yang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Tsung-Ying Yang has a total of 74 co-authors. Here are the top co-authors by number of shared publications:
- Sung-Pin Tseng
Department of Medical Laboratory Science and Biotechnology, College of Health Sciences, Kaohsiung Medical University, Kaohsiung 807378, Taiwan
9 shared publications - Liang-Chun Wang
Department of Marine Biotechnology and Resources, National Sun Yat-Sen University, Kaohsiung, Taiwan
7 shared publications - Po-Liang Lu
Division of Infectious Diseases, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Taiwan; Department of post-baccalaureate Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan
7 shared publications - Chi-Jen Shih
Department of Fragrance and Cosmetic Science, College of Pharmacy, Kaohsiung Medical University, Kaohsiung, Taiwan; Drug Development and Value Creation Research Center, Kaohsiung Medical University, Kaohsiung, Taiwan; Department of Medical Research, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan
5 shared publications - Sheng-Fan Wang
Center for Tropical Medicine and Infectious Disease, Kaohsiung Medical University, Kaohsiung 80708, Taiwan
4 shared publications - Ya-Ju Hsieh
Department of Medical Imaging and Radiological Sciences, Kaohsiung Medical University, Kaohsiung, Taiwan
4 shared publications
Latest Publications
- Open Access
- 1 July 2026
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 70  (7) , e0038726
Molecular epidemiology and emerging tet (X)-associated resistance of Elizabethkingia spp. in Taiwan, 2016–2022
Elizabethkingia species are opportunistic gram-negative pathogens associated with nosocomial infections and limited therapeutic options. Longitudinal data characterizing antimicrobial resistance and molecular determinants in Taiwan remain scarce. A total of 191 non-duplicate Elizabethkingia clinical isolates were collected at the National Taiwan University Hospital between 2016 and 2022. Species identification was confirmed by 16S rRNA sequencing. Elizabethkingia anophelis predominated (81.7%), followed by E. meningoseptica (9.9%) and E. miricola (7.9%). No major clone was identified. Genes involved in sialic acid metabolism were detected as follows: glmS in 93.2% (178/191), glmM in 97.4% (186/191), nagB in 98.4% (188/191), neuC2 in 24.5% (46/191), and neuC in 2.1% (4/191) of isolates. Antimicrobial susceptibility testing showed very high nonsusceptibility for most agents (≥99.5%). Lower rates of nonsusceptibility were observed for levofloxacin (MIC 50 /MIC 90 = 1/>8 µg/mL; 68.6% susceptible), ciprofloxacin (2/>4 µg/mL; 49.2%), tigecycline (4/>8 µg/mL; 23.0%), and rifampin (>8/>16 µg/mL; 19.9%). Using the breakpoint for other non-Enterobacterales, minocycline was active against all isolates (100.0%, 191/191); however, applying the S. maltophilia criteria, 42 isolates (22.0%) were nonsusceptible to minocycline. Among tetracycline determinants, tet (X) was detected in 22 isolates (11.5%) and tet (K) in 2 isolates (1.0%). With the criteria of S. maltophilia , 10 tet (X)-positive isolates (10/22, 45.5%) showed non-susceptibility to minocycline, implying that tet (X) may contribute to the elevated MIC of minocycline. Our surveillance revealed a rapid increase in resistance to fluoroquinolones and rifampin and the emergence of tet (X)-mediated tetracycline resistance in Elizabethkingia spp. These findings underscore the need for continued molecular monitoring and region-specific antimicrobial stewardship.
- 1 July 2026
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 70  (7) , e0038726
Open AccessMolecular epidemiology and emerging tet (X)-associated resistance of Elizabethkingia spp. in Taiwan, 2016–2022
Elizabethkingia species are opportunistic gram-negative pathogens associated with nosocomial infections and limited therapeutic options. Longitudinal data characterizing antimicrobial resistance and molecular determinants in Taiwan remain scarce. A total of 191 non-duplicate Elizabethkingia clinical isolates were collected at the National Taiwan University Hospital between 2016 and 2022. Species identification was confirmed by 16S rRNA sequencing. Elizabethkingia anophelis predominated (81.7%), followed by E. meningoseptica (9.9%) and E. miricola (7.9%). No major clone was identified. Genes involved in sialic acid metabolism were detected as follows: glmS in 93.2% (178/191), glmM in 97.4% (186/191), nagB in 98.4% (188/191), neuC2 in 24.5% (46/191), and neuC in 2.1% (4/191) of isolates. Antimicrobial susceptibility testing showed very high nonsusceptibility for most agents (≥99.5%). Lower rates of nonsusceptibility were observed for levofloxacin (MIC 50 /MIC 90 = 1/>8 µg/mL; 68.6% susceptible), ciprofloxacin (2/>4 µg/mL; 49.2%), tigecycline (4/>8 µg/mL; 23.0%), and rifampin (>8/>16 µg/mL; 19.9%). Using the breakpoint for other non-Enterobacterales, minocycline was active against all isolates (100.0%, 191/191); however, applying the S. maltophilia criteria, 42 isolates (22.0%) were nonsusceptible to minocycline. Among tetracycline determinants, tet (X) was detected in 22 isolates (11.5%) and tet (K) in 2 isolates (1.0%). With the criteria of S. maltophilia , 10 tet (X)-positive isolates (10/22, 45.5%) showed non-susceptibility to minocycline, implying that tet (X) may contribute to the elevated MIC of minocycline. Our surveillance revealed a rapid increase in resistance to fluoroquinolones and rifampin and the emergence of tet (X)-mediated tetracycline resistance in Elizabethkingia spp. These findings underscore the need for continued molecular monitoring and region-specific antimicrobial stewardship.
- Open Access
- 5 June 2026
- Published by Elsevier in International Dental Journal
- Vol. 76  (4) , 109645
A Longitudinal Study of Antimicrobial Resistance in Oral Bacterial Isolates From Periodontitis Patients in Taiwan
- 5 June 2026
- Published by Elsevier in International Dental Journal
- Vol. 76  (4) , 109645
Open AccessA Longitudinal Study of Antimicrobial Resistance in Oral Bacterial Isolates From Periodontitis Patients in Taiwan
- Open Access
- 11 May 2026
- Published by Elsevier in SSRN Electronic Journal
Glucose-Derived Carbon-Confined Cu Nanoparticles Drive Selective NO3RR-to-NH4+ in Acid and Resist Biofouling in Wastewater
Electrochemical nitrate reduction to ammonia (NO3RR) enables simultaneous denitrification and value-added ammonia production; however, achieving high selectivity and long-term durability in strongly acidic, microbe-rich wastewater remains challenging. In this study, glucose-confined Cu nanoparticle catalyst (CuNC@Glu800A800 is reported, where NC denotes N-doped carbon). The glucose-derived carbon shell suppresses Cu oxidation and aggregation, promotes a conductive porous architecture, and enriches dispersed Cu0/Cu+ sites. As a result, CuNC@Glu800A800 delivers a Faradaic efficiency of approximately 100% at a current density of −58.7 mA cm−2 and an NH4+ yield of 599 mmol h−1 cm−2 at −0.5 V vs reversible hydrogen electrode (RHE) in 0.1 M H2SO4 containing 0.1 M KNO3, without any nitrite accumulation. Operando Raman spectroscopy and electrokinetic analyses support a stepwise nitrate reduction pathway with suppressed hydrogen evolution. In stability tests, the electrode retains approximately 87% of its activity over 8 h and, after 16 h of electrolysis, preserves approximately 91.5% of its initial Cu content, indicating minimal leaching. Notably, CuNC@Glu800A800 exhibits intrinsic antibacterial activity against Escherichia coli, Pseudomonas aeruginosa, and Enterococcus faecalis, achieving >99.9% growth inhibition within 24 h. Beyond catalytic performance, this antibiofouling functionality mitigates biofilm-associated decay, enabling practical electrolysis of real pond wastewater (pH 8.5) with sustained NH4+ production. This work highlights a robust, multifunctional cathode design for integrated nitrate remediation and sustainable ammonia electrosynthesis in complex wastewater systems.
- 11 May 2026
- Published by Elsevier in SSRN Electronic Journal
Open AccessGlucose-Derived Carbon-Confined Cu Nanoparticles Drive Selective NO3RR-to-NH4+ in Acid and Resist Biofouling in Wastewater
Electrochemical nitrate reduction to ammonia (NO3RR) enables simultaneous denitrification and value-added ammonia production; however, achieving high selectivity and long-term durability in strongly acidic, microbe-rich wastewater remains challenging. In this study, glucose-confined Cu nanoparticle catalyst (CuNC@Glu800A800 is reported, where NC denotes N-doped carbon). The glucose-derived carbon shell suppresses Cu oxidation and aggregation, promotes a conductive porous architecture, and enriches dispersed Cu0/Cu+ sites. As a result, CuNC@Glu800A800 delivers a Faradaic efficiency of approximately 100% at a current density of −58.7 mA cm−2 and an NH4+ yield of 599 mmol h−1 cm−2 at −0.5 V vs reversible hydrogen electrode (RHE) in 0.1 M H2SO4 containing 0.1 M KNO3, without any nitrite accumulation. Operando Raman spectroscopy and electrokinetic analyses support a stepwise nitrate reduction pathway with suppressed hydrogen evolution. In stability tests, the electrode retains approximately 87% of its activity over 8 h and, after 16 h of electrolysis, preserves approximately 91.5% of its initial Cu content, indicating minimal leaching. Notably, CuNC@Glu800A800 exhibits intrinsic antibacterial activity against Escherichia coli, Pseudomonas aeruginosa, and Enterococcus faecalis, achieving >99.9% growth inhibition within 24 h. Beyond catalytic performance, this antibiofouling functionality mitigates biofilm-associated decay, enabling practical electrolysis of real pond wastewater (pH 8.5) with sustained NH4+ production. This work highlights a robust, multifunctional cathode design for integrated nitrate remediation and sustainable ammonia electrosynthesis in complex wastewater systems.
- Open Access
- 27 August 2025
- Published by Elsevier in Journal of Microbiology, Immunology and Infection
- Vol. 59  (3) , 301-309
Enzyme-linked immunosorbent STI assays: development, current status and future perspective
- 27 August 2025
- Published by Elsevier in Journal of Microbiology, Immunology and Infection
- Vol. 59  (3) , 301-309
Open AccessEnzyme-linked immunosorbent STI assays: development, current status and future perspective
- Open Access
- 22 January 2025
- Published by Elsevier in Journal of Microbiology, Immunology and Infection
- Vol. 58  (3) , 347-355
Synergistic effect between taurine-induced silver ion and itraconazole against azole-resistant Candida species and Candida auris
- 22 January 2025
- Published by Elsevier in Journal of Microbiology, Immunology and Infection
- Vol. 58  (3) , 347-355
Open AccessSynergistic effect between taurine-induced silver ion and itraconazole against azole-resistant Candida species and Candida auris
- 30 December 2024
- Published by Elsevier in Journal of Dentistry
- Vol. 153, 105549
Assessment of silver-copper co-loaded mesoporous bioactive glass as an advanced pulp-capping material
- 30 December 2024
- Published by Elsevier in Journal of Dentistry
- Vol. 153, 105549
Assessment of silver-copper co-loaded mesoporous bioactive glass as an advanced pulp-capping material
- Open Access
- 8 May 2024
- Published by Elsevier in Journal of Dental Sciences
- Vol. 20  (1) , 510-521
Antimicrobial properties of bimetallic-containing mesoporous bioglass against Enterococcus faecalis
- 8 May 2024
- Published by Elsevier in Journal of Dental Sciences
- Vol. 20  (1) , 510-521
Open AccessAntimicrobial properties of bimetallic-containing mesoporous bioglass against Enterococcus faecalis
- Open Access
- 5 September 2023
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 24  (18) , 13679
Synthesis, Characterization, and Bioactivity of Mesoporous Bioactive Glass Codoped with Zinc and Silver
Due to the overconsumption of antimicrobials, antibiotic-resistant bacteria have become a critical health issue worldwide, especially methicillin-resistant S. aureus (MRSA) and vancomycin-resistant E. faecalis (VRE). Recently, many efforts have been made to load metals into bioactive glasses to enhance the multifunctionality of materials, such as antibacterial and osteoinductive functions. Zinc has been documented to stimulate the gene expression of various regulatory factors in bone cells. Meanwhile, previous studies have reported that silver and zinc could be a promising antibacterial combination with synergistic antimicrobial effects. Here, we sought to develop a biomaterial coreleasing zinc and silver, designated 80S-ZnAg, and to evaluate its antibacterial activity and biocompatibility. The textural analyses demonstrated different coreleasing patterns of zinc and silver for the materials. The chemical characterization revealed that the zinc in 80S-ZnAg could be the network modifier when its molar ratio was high, releasing more zinc; zinc could also be the network former when its molar ratio was low, showing an extremely low rate of release. However, the ICP results for 80S-Zn3Ag2 demonstrated up to 7.5 ppm of zinc and 67.6 ppm of silver. Among all the 80S-ZnAg materials, 80S-Zn3Ag2 demonstrated more marked antibacterial activity against MRSA and VRE than the others, with inhibition zones of 11.5 and 13.4 mm, respectively. The cytotoxicity assay exhibited nearly 90% cell viability at 20 mg/mL of 80-Zn3Ag2. Further clinical study is needed to develop an innovative biomaterial to address the issue of antibiotic resistance.
- 5 September 2023
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 24  (18) , 13679
Open AccessSynthesis, Characterization, and Bioactivity of Mesoporous Bioactive Glass Codoped with Zinc and Silver
Due to the overconsumption of antimicrobials, antibiotic-resistant bacteria have become a critical health issue worldwide, especially methicillin-resistant S. aureus (MRSA) and vancomycin-resistant E. faecalis (VRE). Recently, many efforts have been made to load metals into bioactive glasses to enhance the multifunctionality of materials, such as antibacterial and osteoinductive functions. Zinc has been documented to stimulate the gene expression of various regulatory factors in bone cells. Meanwhile, previous studies have reported that silver and zinc could be a promising antibacterial combination with synergistic antimicrobial effects. Here, we sought to develop a biomaterial coreleasing zinc and silver, designated 80S-ZnAg, and to evaluate its antibacterial activity and biocompatibility. The textural analyses demonstrated different coreleasing patterns of zinc and silver for the materials. The chemical characterization revealed that the zinc in 80S-ZnAg could be the network modifier when its molar ratio was high, releasing more zinc; zinc could also be the network former when its molar ratio was low, showing an extremely low rate of release. However, the ICP results for 80S-Zn3Ag2 demonstrated up to 7.5 ppm of zinc and 67.6 ppm of silver. Among all the 80S-ZnAg materials, 80S-Zn3Ag2 demonstrated more marked antibacterial activity against MRSA and VRE than the others, with inhibition zones of 11.5 and 13.4 mm, respectively. The cytotoxicity assay exhibited nearly 90% cell viability at 20 mg/mL of 80-Zn3Ag2. Further clinical study is needed to develop an innovative biomaterial to address the issue of antibiotic resistance.
- Open Access
- 16 July 2023
- Published by Elsevier in Journal of Microbiology, Immunology and Infection
- Vol. 56  (5) , 1016-1025
Potentials of organic tellurium-containing compound AS101 to overcome carbapenemase-producing Escherichia coli
- 16 July 2023
- Published by Elsevier in Journal of Microbiology, Immunology and Infection
- Vol. 56  (5) , 1016-1025
Open AccessPotentials of organic tellurium-containing compound AS101 to overcome carbapenemase-producing Escherichia coli
- Open Access
- 13 April 2023
- Published by American Society for Microbiology in Microbiology Spectrum
- Vol. 11  (2) , e0149622
In Vitro Evaluation of Tellurium-Based AS101 Compound against Neisseria gonorrhoeae Infectivity
Neisseria gonorrhoeae is an obligate human pathogen responsible for gonorrhea, one of the most common sexually transmitted infections. The yearly increased multidrug resistance in GC has led to treatment failure clinically, suggesting an urgent need for novel therapy to combat the global health issue.
- 13 April 2023
- Published by American Society for Microbiology in Microbiology Spectrum
- Vol. 11  (2) , e0149622
Open AccessIn Vitro Evaluation of Tellurium-Based AS101 Compound against Neisseria gonorrhoeae Infectivity
Neisseria gonorrhoeae is an obligate human pathogen responsible for gonorrhea, one of the most common sexually transmitted infections. The yearly increased multidrug resistance in GC has led to treatment failure clinically, suggesting an urgent need for novel therapy to combat the global health issue.